Abstract
To maintain magnetic properties, physical properties, and bio-applicability, a liposomal structure is introduced to the magnetic MNP@mSiO2 (MagLipo). EGFR-antibody-conjugated MagLipo is successfully applied for T2-w imaging and magnetic sensing after specific targeting to BxPC3 pancreatic cancer. Furthermore, the MagLipo carrying a therapeutic drug and gene shows a high therapeutic effect with drug release in a pH-sensitive manner in vitro.
| Original language | English |
|---|---|
| Pages (from-to) | 242-247 |
| Number of pages | 6 |
| Journal | Particle and Particle Systems Characterization |
| Volume | 33 |
| Issue number | 5 |
| DOIs | |
| State | Published - 1 May 2016 |
Bibliographical note
Publisher Copyright:© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Keywords
- cancer targeting
- drug and gene delivery
- magnetic iron oxide nanoparticle
- magnetic sensing
- mesoporous silica shell